AEON(AEON)
AEON
Key MetricsTTM
Market Cap$9.19M
Revenue TTM$0.00
Net Income TTM-$60.11M
Free Cash Flow-$12.04M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity223.7%
Return on Assets-696.5%
Debt / Equity-0.16
Current Ratio0.99
EPS TTM$-4.97
PRICE
Prev Close
0.82
Open
0.82
Day Range0.75 – 0.82
0.75
0.82
52W Range0.52 – 1.45
0.52
1.45
28% of range
VOLUME & SIZE
Avg Volume
101.4K
FUNDAMENTALS
P/E Ratio
-0.1x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
41
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 119 days
Sep 18
AEON News
About
we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, cfo oleg grodnensky and chief legal officer david meredith.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Chad K. OhChief Medical Officer
Alex WilsonChief Legal and Strategy Officer & Corporate Secretary
John A. BencichChief Financial Officer
Robert BancroftPresident, Chief Executive Officer & Director
Jennifer SyChief Accounting Officer